The CMO’s annual plan, the board view
A hospital marketing strategy in India earns board funding when it is built from unit-level demand pools and payback, not a channel calendar. This piece covers how the plan ties to OPD, IPD, international and insurance demand, what boards push back on, and why only a two-page version of the plan actually survives the meeting.
Every year I have built an annual marketing plan, I have built two versions of it without quite meaning to. The first is the real plan — the one with the channel mix, the CRM roadmap, the campaign calendar by specialty, the hiring requests. The second is the version that actually gets discussed in the board meeting, which is shorter, blunter, and organised around questions I did not choose. The gap between those two documents is where most marketing heads lose the room, not in the quality of their thinking.
A board does not evaluate a marketing plan the way a marketing head does. It is not asking whether the creative is good or the media mix is efficient. It is asking whether this function, given a certain amount of money, will move revenue by a predictable amount, in a predictable place, without creating a risk the group cannot see coming. Everything else in the plan is supporting material.
This is the version of annual planning that survives that room: how the plan is built from unit-level demand rather than a channel calendar, how spend gets defended against a profit and loss statement rather than a dashboard, what a board actually pushes back on, and how the plan sequences its bets across four quarters instead of asking for the whole budget on day one.
Start from demand pools, not from channels
A channel-first plan reads well to a marketing team and means nothing to a board. Search, social, CRM, contact centre, referral outreach — a board does not have opinions about the mix between them. What it has opinions about is where the patients actually come from and whether that mix is healthy.
So the plan has to start from the demand pools a hospital group actually runs on: OPD footfall in the local catchment, IPD conversion from that OPD base, the international desk, and the insurance and TPA channel that increasingly decides what a bed is worth once it is filled. Each pool has a different sales cycle, a different cost structure, and a different owner on the ground. A plan that treats them as one blended acquisition number cannot be defended, because the first question from the room is almost always which pool a rupee of spend is meant to grow, and a blended plan has no answer.
Building the plan this way also forces an honest conversation before the board ever sees it. Some units are OPD-constrained and need demand. Others are IPD-constrained and need conversion, not more enquiries. A plan that pushes the same channel mix into both is asking for the same money to do two different jobs, and it usually does neither well.
Spend gets defended against a P&L line, not a funnel
The plan that gets funded ties every meaningful spend line to a number finance already tracks: cost per admission by specialty, contribution by payer mix, receivables days on the insurance book, occupancy against the capacity a unit actually has. Click-through rates, cost per lead, and engagement scores do not appear in this version at all, because nobody on the board is fluent in them and nobody should have to become fluent in them to approve a budget.
This is a harder discipline than it sounds, because a marketing head’s own tools report in funnel metrics by default, and translating them into P&L language takes real work with finance before the deck exists. I have sat in reviews where the CRM programme looked strong on every marketing metric and weak on the one that mattered — contribution per retained patient — because the retention gains were concentrated in a low-margin specialty. The board was right to ask about it, and the only good answer was one built from the same numbers that show up when you read the monthly finance pack the way finance reads it, not the way a campaign report reads it.
Digital and CRM spend in particular needs its own defence, because it is the line most easily read as overhead rather than growth. The case has to show what the platform changes about conversion or retention in terms finance recognises — fewer lost enquiries, a shorter path from enquiry to appointment, a lower cost of re-acquiring a patient who has already been treated once. A CRM renewal justified on seat licences and message volume gets cut in the first pass. One justified on the appointments it protects usually does not.
What the board actually pushes back on
After enough of these meetings, the pattern of pushback becomes predictable, and a plan built without anticipating it will get picked apart live in the room.
- Payback period. Not whether the spend is justified in principle, but how many months before it pays for itself, and what happens to the plan if that period slips by a quarter.
- Channel concentration risk. How much of the demand pipeline depends on one platform, one aggregator relationship, or one algorithm change outside anyone’s control.
- Doctor dependency. How much of the demand the plan projects actually rides on two or three senior consultants, and what the plan looks like if one of them leaves.
- Capacity fit. Whether the demand this spend is meant to generate can actually be processed by the units in question, or whether it will simply lengthen the wait list.
Doctor dependency is the one marketing heads underweight most, because it feels like someone else’s problem. It is not. A demand plan that leans on a handful of named consultants for a large share of projected volume is fragile in a way the board can see instantly, and the mitigation the board wants to see is one the plan has to state explicitly — treating brand as a demand asset in its own right, alongside a broader referral base and service lines with more than one credible doctor. A plan that cannot show that will be read as a risk register with a marketing budget attached.
Sequencing the year instead of asking for it all at once
A plan that requests the full annual budget upfront, spread evenly across twelve months, is asking the board to trust a full year of assumptions in one sitting. A plan that sequences the spend earns trust in smaller, reviewable steps, and it is far easier to defend because each stage has evidence behind it rather than a projection.
The shape I use is roughly this. The first quarter funds the smallest defensible version of anything new — a pilot channel, a new CRM workflow, a Tier 2 catchment test — alongside the steady-state spend that keeps existing demand pools fed. The second quarter scales whatever the pilot proved and holds back on what it did not, with a checkpoint the board can actually see. The back half of the year carries the larger, higher-conviction bets: a new market entry, a heavier push into a specialty with spare capacity, an insurer or TPA relationship worth investing in ahead of the empanelment cycle. Government scheme volume and insurer negotiations both move on their own calendars, not the marketing calendar, and a sequenced plan can absorb that timing instead of fighting it.
This sequencing also protects the CMO. A plan that commits the full budget in January has nothing left to say when a channel underperforms in April except to ask for more. A plan that holds a genuine reserve, tied to the checkpoints above, can reallocate without going back to the board for a fresh approval every time the market moves.
The plan you build and the plan that survives the room
The working plan — the one the marketing team actually executes against — can run to forty or fifty pages: channel calendars, creative briefs, CRM segmentation, hiring plans, vendor scopes. Most of that detail sits well inside what the CMO role owns today, which is wider than the campaign calendar alone, but none of it belongs in front of the board. Trying to walk a committee through it is the single fastest way to lose their attention before the number that matters ever comes up.
What survives the room is two pages. The first is demand and revenue by pool, with the spend against each and the payback assumption stated plainly. The second is risk: concentration, doctor dependency, and the one or two things that could make the plan wrong, with what the CMO is doing about each. Everything else — the reasoning, the channel detail, the campaign calendar — sits behind those two pages as an appendix nobody asks for unless something looks wrong.
Writing the two-page version first, before the forty-page one, changes how the whole plan gets built. It forces the same discipline the board will apply anyway, earlier, when there is still time to fix a weak assumption rather than defend it live. I now build the two pages in the first week of planning and treat the detailed version as the working document that has to earn its place inside it, not the other way round.
Where this plan gets its credibility
A board does not fund a plan because the logic is sound. It funds a plan because the person presenting it has been right often enough, in front of that room, that the assumptions are given the benefit of the doubt. That credibility is built well before the meeting, in the unit P&L reviews where the same numbers get discussed at a smaller scale, and in the previous year’s plan actually landing close to what was promised.
This is also where accountability for the whole revenue line pays off, because a CMO who only ever speaks to enquiries and campaigns has no credibility on payback, capacity fit, or payer mix — those conversations belong to whoever owns the number, and if that is not you, the board will simply wait for someone who does own it to answer. The annual plan is where that accountability either shows up as command of the numbers or gets exposed as a marketing narrative dressed up as a growth one.
The order of operations
- Build the plan from unit-level demand pools — OPD, IPD, international, insurance and TPA — before touching a channel calendar.
- Translate every meaningful spend line into a number finance already tracks, before the deck exists, working with finance directly rather than after the fact.
- Write the two-page board version first: demand and payback by pool, then risk. Build the working plan to fit inside it.
- Name the channel concentration and doctor dependency risks yourself, with a mitigation, before the board names them for you.
- Sequence spend across four quarters with a genuine reserve, not an even split across twelve months.
- Rehearse the two-page version against the last twelve months of unit P&L reviews, not against last year’s marketing deck.
The plan that gets funded is not the most thorough one. It is the one that already answers the questions the room was always going to ask.
Questions people ask
It is the annual plan for how a hospital or hospital group generates and converts demand across OPD, IPD, international and insurance channels, tied to a rupee budget and a revenue outcome. In an Indian private hospital, that plan has to account for TPA and government scheme volume alongside cash-paying patients, which most generic marketing-strategy templates ignore entirely.
A payback period stated in months for every major spend line, not a campaign narrative. I would also ask which demand pool each rupee is meant to grow, what happens to the plan if a channel underperforms by a quarter, and whether the projected demand can actually be processed by unit capacity rather than just added to a wait list.
Payback period by major spend line, alongside how much of projected demand depends on a small number of named consultants. Revenue and enquiry growth numbers matter less to a board than whether the plan can be trusted to behave the way it says it will if one assumption breaks.
Expect six to eight weeks if the underlying demand-pool and payer data already exists in a usable form, longer if it has to be assembled unit by unit first. The two-page board version should be drafted early, in the first week, so the detailed working plan is built to support it rather than compressed into it afterward.
Fund the smallest defensible pilot in the first quarter, scale what it proves in the second, and reserve the larger, higher-conviction bets for the back half of the year once evidence exists. Keep a genuine reserve rather than committing the full budget upfront, so the plan can absorb a channel underperforming without going back to the board for a fresh approval.
Presenting a channel calendar instead of a demand-pool plan, reporting in funnel metrics the board is not fluent in, and leaving doctor dependency or channel concentration risk for the board to discover rather than naming it first. A plan that asks for the full year’s budget in one sitting, with no reserve, tends to get the hardest questions.
It means how much of the projected demand rides on two or three senior consultants rather than the broader service line or brand. A medical director should care because a plan overly reliant on named doctors is fragile if one leaves, and the honest fix involves broadening referral relationships and service-line depth, not just marketing spend.
Cost per admission by specialty, contribution by payer mix, receivables days on the insurance book, and occupancy against actual unit capacity. Most of this sits with finance already; the work is translating marketing’s own funnel metrics into these terms before the board meeting, not during it.
The CMO or growth head owns the plan, but it cannot be built alone. It needs input from finance on payback and contribution, from unit heads on capacity, and from the medical leadership on doctor dependency. A plan built in a marketing silo and only shown to finance the week before the board meeting rarely survives intact.
That the plan is being defended against payback and unit-level demand pools, not campaign metrics, so a proposal pitched purely on reach or engagement numbers will not survive the internal review. Vendors who can speak in cost-per-admission or conversion terms, and who understand the payer mix constraint, get taken more seriously into the plan.
The discipline applies at any scale; the complexity scales with the number of units. A single hospital still has OPD, IPD and possibly an insurance channel to plan across, and a board or promoter group still wants payback and risk in two pages rather than a channel calendar, even if the underlying detail is simpler.
Almost always, unless every assumption in the plan has already been tested. Asking for the full year in one sitting removes the ability to reallocate if a channel underperforms or a scheme empanelment shifts timing, and it asks the board to trust twelve months of projections without a single checkpoint along the way.
A change in conversion or retention stated in terms finance recognises, such as fewer lost enquiries or a lower cost of re-acquiring an already-treated patient, rather than seat licences or message volume. A CRM renewal defended on the appointments it protects tends to survive; one defended on activity metrics usually gets cut first.
